Condition

Esophageal and Gastric Varices

ClinicalTrials.gov condition label

Clinical trials28

Recruiting2

Common interventions25

Lead sponsors shown15

Clinical trials

28 shown

Apixaban-PK Trial: Preventing Portal Hypertension Complications in CirrhosisNCT07521332 · 2026-04-01

The Diagnostic Value of Subharmonic Imaging Technology Combined With Liver Stiffness and Platelet Count for High-risk Esophageal and Gastric Varices in Patients With Liver CirrhosisNCT07151885 · 2025-08-31

Pantoprazole After Prophylactic Endoscopic Variceal TreatmentNCT07248722 · 2026-03-27

ENROLLING_BY_INVITATION

Study on Portal Vein Pressure Gradient Measurement Under Endoscopic Ultrasound Guidance for Gastric Fundal VaricesNCT07478770 · 2025-07-01

Evaluation of Endoscopic Treatment Effect Based on HVPGNCT06863519 · 2024-11-01

ENROLLING_BY_INVITATION

Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver CirrhosisNCT03130127 · 2024-07-01

Clinical Study on Endoscopic Management of GOV1 Esophagogastric VaricesNCT05978752 · 2023-12-01

Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin TherapyNCT05331768 · 2021-01-01

A Randomized Controlled Study on the Treatment of Cirrhosis Combined With HypersplenismNCT05055713 · 2020-09-25

The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver CirrhosisNCT04823780 · 2020-09-01

Safety of Anticoagulant Therapy After Endoscopic TreatmentNCT04976543 · 2020-02-01

TIPS Plus Transvenous Obliteration for Gastric VaricesNCT04044248 · 2019-04-04

Development and Validation of an Noninvasive Model for Predicting High Risk Esophageal Varices in CirrhosisNCT04210297 · 2018-01-01

Rifaximin in Patients With Gastroesophageal Variceal BleedingNCT02991612 · 2016-11-25

Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal BleedingNCT02964195 · 2016-11-01

Study the Safety and Efficacy of "Compont Medical Glue" in the Treatment of Esophagogastric VaricesNCT02945930 · 2016-09-01

Trial of Monthly Versus Bi-weekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal RebleedingNCT02719119 · 2016-03-01

The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal BleedingNCT02695732 · 2015-12-01

Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational StudyNCT02593799 · 2015-05-01

The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal BleedingNCT02385422 · 2015-03-01

Predictive Factors and Outcome of Esophageal Ulcers After Endoscopic Treatment of Esophageal VaricesNCT02256046 · 2014-08-01

Effects of Terlipressin When Usual Somatostatin or Octreotide Dose FailsNCT02311608 · 2014-02-01

HEMOCC Study. Hemostasis in Cirrhotic Children.NCT03244332 · 2013-10-18

Carvedilol as an Adjunct to Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal BleedingNCT02504723 · 2011-12-01

Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal BleedingNCT00838864 · 2009-03-01

Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule EndoscopyNCT00475592 · 2007-01-01

Decompression Intervention of Variceal Rebleeding Trial (DIVERT)NCT00006161 · 1996-12-01

Prevention of Esophageal Varices by Beta-Adrenergic BlockersNCT00006398 · 1993-08-01

Common interventions

CarvedilolDRUG4 PlaceboDRUG2 RifaximinDRUG2 TerlipressinDRUG2 ApixabanDRUG1 banding ligation plus terlipressin infusionCOMBINATION_PRODUCT1 bi-weekly Endoscopic Variceal Ligation (EVL)PROCEDURE1 ceftrioxoneDRUG1 Collecting Clinical DataOTHER1 Collecting laboratory dataOTHER1 cyanoacrylateDRUG1 Distal Splenorenal ShuntPROCEDURE1 Endoscopic gel embolization of gastric fundus varices and ligation of esophageal varicesPROCEDURE1 Endoscopic gel embolization of gastric fundus varices and sclerotherapy of esophageal varicesPROCEDURE1 Endoscopic gelatinous embolization of gastric varices (esophageal varices not treated)PROCEDURE1 Endoscopic therapyPROCEDURE1 Endoscopic therapy+ beta blockersPROCEDURE1 Endoscopic therapy+ PSEPROCEDURE1 Endoscopic therapy+ PSE+beta blockersPROCEDURE1 Endoscopic therapy+PSE+SomatostatinPROCEDURE1 Endoscopic therapy+SomatostatinPROCEDURE1 Endoscopic treatmentPROCEDURE1 endoscopyDEVICE1 EndoscopyPROCEDURE1 Esophageal Capsule EndoscopyDEVICE1

Leading sponsors

Shanghai Zhongshan Hospital6 Qilu Hospital of Shandong University4 General Hospital of Shenyang Military Region3 Second Affiliated Hospital, Zhejiang University, School of Medicine3 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2 Asian Institute Of Medical Sciences1 Cliniques universitaires Saint-Luc- Université Catholique de Louvain1 Far Eastern Memorial Hospital1 Instituto Mexicano del Seguro Social1 Johns Hopkins University1 Kaohsiung Veterans General Hospital.1 Tanta University1 The First Hospital of Jilin University1 University of Illinois at Chicago1 West China Hospital1

Trial status mix

COMPLETED13

UNKNOWN10

ENROLLING_BY_INVITATION2

RECRUITING2

WITHDRAWN1

Phase mix

NA12

PHASE46

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.